Iboganautics

Unveiling the iboga experience for first-timers and shamans alike, Iboganautics is the podcast committed to discovering everything there is to know about "Tabernanthe iboga," or simply called iboga, a naturally occurring psychedelic plant from Gabon in western Central Africa. While other podcasters and content producers mainly focus on the addiction interruption properties of ibogaine, the main acting alkaloid in iboga, there is so much more to discuss, so much more one could and should know for a richer appreciation of the experience. For this reason, I invite members of the iboga community and other experts on the podcast to speak not just about addiction but about alternative topics pertaining to iboga-the-plant as well as the subjective experiences elicited by iboga. After several transformative personal experiences in addition to my own academic research, I speak with people that have something educational and interesting to say about this substance/experience, directly or indirectly related; for example, from scholars in neuroscience, philosophy, psychology, anthropology, and botany to experienced staff at retreat centers, artists, lay experts, and so on. While there’s much good information about iboga across multiple media, I believe there’s more to discover by conversing with said experts. For more information, visit https://amhouot.com/iboganautics/

All Episodes

Iboganautics

2.0_The Body on Iboga

August 22, 2020 • A.M.

Welcome to . . . Iboganautics: Unveiling the iboga experience for first-timers and shamans alike. I’m your host, A.M. Season 2, The Body on Iboga, is about the physical aspects of the iboga experience people should consider. The main questions that guide each episode are: “What is happening to my body while on iboga,” and, “How am I experiencing my body while on iboga”? In this season, Tricia Eastman (ep2.1), a Bwiti-trained shaman, speaks about sober supervision and caretaking of iboga participants. Fitness coach and nutritionist, Matt Cooper (ep2.2), tells us how to prevent muscle cramps and soreness during experiences, and what nutritional choices one can make in order to give the body the best chance at processing iboga. Dr. Tibor M. Brunt (ep2.3), a Dutch addiction scientist, speaks about the cardiotoxic risks of iboga, particularly regarding QT prolongation and torsades de pointes. To better understand the eye—brain axis and hallucinogen persisting perception disorder, also known as HPPD, neuro-ophthalmologist professor Dr. Andrew G. Lee (ep2.4) explains the physical mechanisms underlying visual perceptual hallucinations and illusions caused by psychedelics. Joaquín González (ep2.5), a Uruguayan sleep neuroscientist, discusses his research on ibogaine and its effects on sleep deprivation and REM sleep. And Dr. Kenneth L. Koch (ep2.6), a professor of gastroenterology, teaches us about nausea, vomiting, and what happens to our bodies when we eat ibogaine-containing wood products. Keep an eye out for additional episodes to be released in Season 2. For more information about me and my work regarding psychedelic technology and philosophy of psychedelics in general, visit my website at https://amhouot.com/

CONNECT

Twitter (https://twitter.com/AMhouot)

Linked In (https://www.linkedin.com/in/amhouot/)

Academia (https://independent.academia.edu/AMHouot)

ResearchGate (https://www.researchgate.net/profile/Am_Houot)

DISCLAIMER

Iboganautics is a podcast intended for entertainment purposes only and all content shared on Iboganautics is for entertainment purposes only. This podcast is not intended to be a substitute for professional legal or medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider or legal counsel with any questions you may have regarding a medical condition or legal situation. Never disregard professional medical advice or delay in seeking it because of something you have heard on this podcast. Neither Iboganautics nor any of its affiliates, sponsors, producers, guests, or hosts encourage the illegal use of controlled substances.